2 recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Complement Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) CTx001 - Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase 1 / Phase 2 | Recruiting | Complement Therapeutics | 75 | 2025-12-30 | 2026-10-16 |
| A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Geographic Atrophy Secondary to Age-related Macular Degeneration | Recruiting | Complement Therapeutics | 75 | 2025-07-30 | 2026-10-16 | |
| Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study Dry Age-related Macular Degeneration, Geographic Atrophy | Completed | Complement Therapeutics | 234 | 2023-02-07 | 2026-10-28 |
Geographic Atrophy (2) · Macular Degeneration (2) · Anetoderma (1) · Eye Diseases (1) · Retinal Degeneration (1) · Retinal Diseases (1)
United Kingdom (3) · United States (3)
Marta Ugarte (1)